These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37866808)

  • 1. Modulation of PI3K/Akt/GSK3β signaling cascade through G protein-coupled receptor 55 (GPR55) activation: Prenatal lysophosphatidylinositol attenuates valproic acid-induced synaptic abnormalities and mitochondrial dysfunction.
    Ahmed S; Abir AH; Sharmin O; Khurshid N; Akter A; Nakshy NT; Hasan MM; Yesmine S; Rahman M
    Life Sci; 2023 Dec; 334():122195. PubMed ID: 37866808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.
    Piñeiro R; Maffucci T; Falasca M
    Oncogene; 2011 Jan; 30(2):142-52. PubMed ID: 20838378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling.
    Calvillo-Robledo A; Cervantes-Villagrana RD; Morales P; Marichal-Cancino BA
    Life Sci; 2022 Jul; 301():120596. PubMed ID: 35500681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of valproic acid-induced dendritic spine and synaptic impairment in the prefrontal cortex for causing core autistic symptoms in mice].
    Wang F; Wang L; Xiong Y; Deng J; Lü M; Tang B; Zhang X; Li Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):101-107. PubMed ID: 35249876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
    Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic Acid Protects Primary Dopamine Neurons from MPP
    Zhang C; Yuan X; Hu Z; Liu S; Li H; Wu M; Yuan J; Zhao Z; Su J; Wang X; Liao Y; Liu Q
    Biomed Res Int; 2017; 2017():8124501. PubMed ID: 28421199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hypothetic role of minocycline as a neuroprotective agent against methylphenidate-induced neuronal mitochondrial dysfunction and tau protein hyper-phosphorylation: Possible role of PI3/Akt/GSK3β signaling pathway.
    Salehi P; Shahmirzadi ZY; Mirrezaei FS; Shirvani Boushehri F; Mayahi F; Songhori M; Abofazeli M; Motaghinejad M; Safari S
    Med Hypotheses; 2019 Jul; 128():6-10. PubMed ID: 31203911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning.
    Mosca MG; Mangini M; Cioffi S; Barba P; Mariggiò S
    Cell Commun Signal; 2021 Apr; 19(1):48. PubMed ID: 33902596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor.
    Lingerfelt MA; Zhao P; Sharir HP; Hurst DP; Reggio PH; Abood ME
    Biochemistry; 2017 Jan; 56(3):473-486. PubMed ID: 28005346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate Attenuates Endoplasmic Reticulum Stress-Induced Apoptosis in SH-SY5Y Cells via the AKT/GSK3β Signaling Pathway.
    Li Z; Wu F; Zhang X; Chai Y; Chen D; Yang Y; Xu K; Yin J; Li R; Shi H; Wang Z; Li X; Xiao J; Zhang H
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
    Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
    J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
    Anavi-Goffer S; Baillie G; Irving AJ; Gertsch J; Greig IR; Pertwee RG; Ross RA
    J Biol Chem; 2012 Jan; 287(1):91-104. PubMed ID: 22027819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.
    Hofmann NA; Yang J; Trauger SA; Nakayama H; Huang L; Strunk D; Moses MA; Klagsbrun M; Bischoff J; Graier WF
    Br J Pharmacol; 2015 Aug; 172(16):4107-18. PubMed ID: 25989290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidylinositol Induced Morphological Changes and Stress Fiber Formation through the GPR55-RhoA-ROCK Pathway.
    Nakajima K; Oka S; Tanikawa T; Nemoto-Sasaki Y; Matsumoto N; Ishiguro H; Arata Y; Sugiura T; Yamashita A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.
    Kallendrusch S; Kremzow S; Nowicki M; Grabiec U; Winkelmann R; Benz A; Kraft R; Bechmann I; Dehghani F; Koch M
    Glia; 2013 Nov; 61(11):1822-31. PubMed ID: 24038453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
    Henstridge CM; Balenga NA; Ford LA; Ross RA; Waldhoer M; Irving AJ
    FASEB J; 2009 Jan; 23(1):183-93. PubMed ID: 18757503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-α-lysophosphatidylinositol meets GPR55: a deadly relationship.
    Ross RA
    Trends Pharmacol Sci; 2011 May; 32(5):265-9. PubMed ID: 21367464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the lysophosphatidylinositol/GPR55 axis in cancer.
    Falasca M; Ferro R
    Adv Biol Regul; 2016 Jan; 60():88-93. PubMed ID: 26588872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse nerve growth factor suppresses neuronal apoptosis in valproic acid-induced autism spectrum disorder rats by regulating the phosphoinositide-3-kinase/serine/threonine kinase signaling pathway.
    Jian J; Li LG; Zhao PJ; Zheng RJ; Dong XW; Zhao YH; Yin BQ; Li S; Cheng H; Li HL; Li EY
    Pharmacogenet Genomics; 2023 Jul; 33(5):101-110. PubMed ID: 37261937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.
    Bondarenko A; Waldeck-Weiermair M; Naghdi S; Poteser M; Malli R; Graier WF
    Br J Pharmacol; 2010 Sep; 161(2):308-20. PubMed ID: 20735417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.